The first enzyme in the de novo serine synthesis pathway (SSP)—phosphoglycerate dehydrogenase (PHGDH) is found up-regulated in melanoma and breast cancers through genomic amplification by increasing the copy number of the gene, which adequately support cancer cell growth in the absence of serine (93, 94). This evidence concerns the gene PHGDH and breast cancer.